The concentration of folylpolyglutamates in liver is 10 -20 !lmol/kg tissue. This concentration is approached by that of the folate-binding sites of several enzymes involved in 1-carbon metabolism, suggesting that a large proportion of cellular folates is protein-bound. Glycine N-methyltransferase and 10-formyl-H 4 PteGlu dehydrogenase have been identified as "folate binding proteins" because of their strong affinity for folylpolyglutamates during gel chromatography. Serine hydroxymethyltransferase may also prove to be a "folate binding protein." Although the folate-binding properties of the above proteins in vivo remain virtually untested, it is likely that the proteins have an effect on the activities of other folate-requiring enzymes, such as thymidylate synthase.
Introduction
Proteins that bind folylpolyglutamates tightly occur in relatively high concentrations in the cell. It is expected that these proteins can limit the rate of flux of i-carbon units through various folate-requiring reactions by sequestering the folate coenzyme. The role of these proteins in limiting the amount of free coenzyme will be discussed . The tightly bound folylpolyglutamates may also control the catalytic function s of the "folate binding proteins" as well, and this role will also be discussed. Folylmonoglutamates, rather than the polyglutamates, are associated with certain Enzymes: AICAR transforrn ylase; aminoimidazolecarboxamide ribonucleotide transform ylase (EC 2.1.2.3). Dihydrofola te reductase (EC 1.5.1 .3). Dimelh ylglycine dehydrogenase (EC 1.5.99.2). Formiminoglutamate: tctra hydrofolate formiminotransferase (EC 2.1.2.5). 10-Formyl-tetrahydrofolate dehydrogenase; 10-formyl-tetra hydrofola te: NADP oxidoreductase (EC 1.5.1.6). GAR transform ylase; glycinamide ribonucleotid e transformylase (EC 2.1.2.2). Methionine synthetase; tetrahydrofolate homocysteine methyltransferase (EC 2.1.1.13). 5,10-Methylene-tetrahydrofolate reductase (EC 1. proteins of the plasma membrane. These proteins therefore are not expected to have a direct and immediate influence on fol ylpolyglutamate-mediated 1-carbon metabolism, and will not be discussed.
The manipulation of folates in normal and cancer cells is of interest to oncologists. For example, the artificial enhancement of the concentration of 5,10-methylene-H 4 folate in cells may increase the inhibition of thymidylate synthase by the drug 5-fluorouracil (1, 2) . Studies concerning the mechanisms of action of methotrexate, 5-fluorouracil, and leucovorin rescue must take into account the influences of the "folate binding proteins."
A knowledge of the proportions of flux of l-carbon units through the pathways represented by thymidylate synthase, methionine synthetase, and GAR and AICAR transformylases is part of one's understanding of i-carbon metabolism . Such a knowledge, in mammalian systems, is limited to observations such as the following: 1) The rate of transfer of l-carbon units from serine to H 4 folate to form 10-formyl-H 4 folate is greater than that from formic acid (3); 2) The utilization of the 1-carbon group of 5-formyl-H 4 folate is relatively greater for the biosynthesis of methionine than for thymidylate in L12i0 cells compared with the utilization in methotrexate-resistant L1210 cells (4); 3) Other studies with L1210 cells demonstrated that the rate of transfer of i-carbon units from folates to make either adenine or guanidine is about three fold greater than to make thymidine (3); and 4) The transfer of i-carbon units from histidine to H 4 folate in the rat seems to be followed by metabolism to 5-methyl-H 4 folate in preference to 10-formyl-H 4 folate (Brody & Stokstad, unpublished). This preference was determined by injecting a rat with 100 f.!Ci of [ring-2-14 C]histidine followed by an analysis that revealed that the specific radioactivity of 5-r 4 C-methyl]H 4 folate was at least five fold greater than that of 10-[ 14 C-formyl]H 4 folate.
The Major Folate Binding Proteins
About half of the folates in the cytoplasm of liver (5) are bound tightly to three proteins, namely, 10-formyl-H 4 PteGlu dehydrogenase (6) , glycine N-methyltransferase (7), and dihydrofolate reductase (8, 9) . A stable elevation (25 -35 fold) in dihydrofolate reductase can occur with the onset of methotrexate resistance in cultured cells (10, 11). Although it is possible that this increase can result in a higher proportion of cellular folylpolyglutamates that are protein-bound, a severe depletion in the free folates is an unlikely consequence, as the cells continue to grow, though at a rate slower than that of the drug-sensitive cells.
The two major "folate binding proteins" are glycine N-methyltransferase and 10-formyl-H 4 PteGlu dehydrogenase, where the methyltransferase binds nearly twice as much of the coenzyme as the dehydrogenase (12) . The concentration of the dehydrogenase subunits in the cell, however, may be greater (4 -12 fold) (13, 14) than those of the methyltransferase (15, 16) ( Table 1 ). There is some thought that glycine Nmethyltransferase binds only one molecule of 5-methyl-H 4 folate per tetramer (17) .
Glycine N-methyltransferase is part of the cell enzymatic machinery for limiting the toxic effects of excess methionine. The methyl groups from the excess amino acid can be funneled off by conversion to Sadenosylmethionine (Ado Met) followed by the transfer to glycine, yielding monomethylglycine (sarcosine) in a reaction catalyzed by the above enzyme (18) . The increased levels of Ado Met also result in the inhibition of 5,10-methylene-H 4 PteGlu reductase, resulting in a depletion of cellular 5-methyl-H 4 folate (19) . In vitro data suggest that decreases in these methyl folates can directly activate glycine N-methyltransferase, thus
Brody: Folate binding proteins speeding the detoxification of methionine (20) . The K for 5-methyl-H4PteGlus (not a substrate) is 0.5 f.!M, a concentration that is clearly within the physiological range.
The 5-methyl-H 4 folate bound to glycine N-methyltransferase may represent a stored form of the vitamin, as the protein seems to be selectively depleted of bound folate in folate-deficient rats. This depletion was shown by the dramatic repletion of bound material following an injection of [3H]folic acid in folatedeficient animals (12) . The enzyme is low in fetal tissues (21) . Rabbit liver contains unusually high levels of the methyl transferase, as determined by enzyme activity assays (21) , as well as high levels of serine hydroxymethyltransferase ( Table 1 ), suggesting that an unusually high proportion of folates in this tissue is associated with protein.
Metabolic studies demonstrating the prompt and near total contraction of the pool of 5-methyl-H 4 folate with a methionine injection (22) and the prompt accumulation of sarcosine following a methionine injection (18) seem not to be consistent with the prolonged and tight association of folate with glycine N-methyltransferase revealed by chromatographic studies. 10-F ormyl-H 4 PteGIu dehydrogenase clearly functions in amino acid metabolism, as shown by the substantial release of 14C-C02 following injections of r 4 C]histidine (22) . However, it is puzzling that an enzyme that is used to catabolize what seem to be valuable 1-carbon units should occur in relatively high concentrations in the cell ( Table 1) . The protein may serve as a "tetrahydrofolate buffer," by binding H 4 folates when their concentration in the cell rises too high. The enzyme is inhibited by tetrahydrofolates, where the K; is under 0.3 f.!M, a concentration clearly within the physiological range (13) . The inhibition by H 4 folates would have an effect complementary to that of the "tetrahydrofolate buffer" function, namely, to increase the ratio of free 10-formyl-H 4 folatejH 4 folate.
Nitrous oxide treatment provokes a contraction of the H 4 folate pool. The concentration of H 4 folate decreased from an inital 52% of the total folate pool down to 38% in one experiment (Brody & Stokstad, in press). One might expect this decrease to result in the release of 10-formyl-H 4 PteGlu dehydrogenase from inhibition, with a consequent depletion of tissue 10-formyl-H 4 folates. This scenario seems not to be supported by data showing that the proportion of liver folates occurring as 10-formyl-H 4 folate was maintained at about 20% with 4.5 h nitrous oxide treatment (Brody & Stokstad, in press). The concentration of enzyme subunits was calculated by dividing the total mg protein in the crude homogenate by the foldincrease in specific activity with purification to homogeneity, a nd dividing by the molecular weight of the subunit. The concentration was expressed on a subunit basis for the sake of uniformity and because the molecula r weights of some of the native enzymes are ambiguous.
') These values (13, 15) are underestimated as they were calculated from the total ~mol of protein recovered without correcting for the percent yield. The yield is difficult to estimate as some activation of the enzymes occurred during purification due to the loss of endogenous inhibitors, i. e., H 4 folate and 5-methyl-H 4 folate. The corrected values, which may either be under or overestimations of the true values, are listed in brackets.
2) The value for glycine N-methyltransferase (16) The concentration of glycine required to provoke the tight binding of folylpolyglutamates to serine hydroxymethyltransferase is 0.1 m M , well below the actual concentration of free glycine in rat liver (5 mM) (24) . The concentration of plasma glycine in the human (25, 26) , dog (27) , and rat (24, 28) , is about 0.2 mM, while that in the pig is higher (1.0 mM) (29) . This suggests that the concentration of glycine in pig liver is at least 1.0 mM.
There is some indication that folates bind to methionine synthetase during its purification (30) . However, because of the low concentration of this enzyme in the cell (Table 1) , there is no reason to suspect that this binding limits the availability of the coenzyme for other reactions.
GAR and AICAR transformylases occur in high concentrations in avian cells ( Table 1) . Folates bind only moderately tightly to these enzymes. The Kill ' S of rolates as well as the Kj of the inhibitor H 2PteGlus for these enzymes are in the 1 -5 ~M range (31 -34) . Dihydrofolate, which expands in concentration with methotrexate treatment (35 -37) , inhibits the activity of AICAR transformylase. The high concentration of this enzyme, at least in avian liver, would tend to minimize the inhibitory effects of the H 2 folate.
Effects on the Activities of Thymidylate Synthase and Methylene Tetrahydrofolate Reductase
Thymidylate synthase may be located in both the cytosol (38) and nucleus (39, 40) . The activity of this enzyme increases in cultured cells (41) and in fetal (42) and regenerating (43) (48) is ten-fold lower than for thymidylate synthase of pig li ver (49) , as well as of other sources (44) . Hence, 5.10-methylene-H 4 PteGlu reductase is unlikely to be as sensitive as thymidylate synthase to changes in the availability of the folate substrate. As noted above, the rate of nux of 1-carbon units via methylene reductase and thymidylate synthase was compared in one study. The concentration of methylene reductase in the cell is low, as is the case for thymidylate synthase. Thus, the tight binding of folates by the reductase (Km = 0.26 and 0.1 ~M for 5,1 O-methylenc-H 4 PteGIus a n d6 (48») would not be expected to influence the availability of folate s to other enzymes.
Methylene reductase tightly binds dihydrofolypolyglutamates. H 1 PteGlu5 inhibits the activity of the reductase with a K i 01'0.19-0.81 ~M (48) . concentrations that might be expected to arise during methotrexate treatment. A result of this inhibition, should it be shown to occur in vivo. would be to spare the folate substrate for use by thymidylate synthase and, possibly to enhance the chemotherapeutic propertics of 5-fluorodeoxyuridylate.
The glycine cleavage system, dimethyl-and monomethylglycine (sarcosine) dehydrogenase. and a unique form of serine hydroxymethyltransferase, reside exclusively in the mitochondria. The concentrations of these proteins on a ~mol/kg tissue basis are relatively low (Table 1 ). The proportion of serine hydroxymethyltransferase activity associated with the mitochondria is not well established, as published figures range from 5% (23) to 40% (50) . This range of figures may have been generated artifactually from differences in sedimentation of the mitochondria with the nuclear fraction, as pointed out by Zamierowski and Wagner (5) . About one third of mitochondrial folates are tightly bound to dimethyl-and monomethylglycine dehydrogenase (5) . Although the bound folate is not required for the expression of enzyme activity (51) , the folate prevents the release of the potentially toxic product, formaldehyde (52) .
Conclusion
An examination of the concentrations of various enzymes in liver and of data, where available, concerning their tendency to bind folylpolyglutamates, revealed that serine hydroxymethyltransferase may be a major folate-binding protein in some animals. The data on concentrations and on binding excluded other enzymes from consideration as major "folate binding proteins ." As yet, little is known of the possible association of folates with the "folate binding proteins" in vivo or on the proposed regulatory effects of the bound folates . The potential importance of the folate binding proteins in regulating the amount of cofactor available for use by thymidylate synthase suggests that the behavior of the binding proteins in normal and cancer cells should be subjected to closer scrutiny.
